Pharmafile Logo
Pharmafocus logo
Advanced Search

CEO

Showing 15 posts of 59 posts found.

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026
Angelini Pharma, CEO

Angelini Pharma, a branch of Angelini Industries, has announced the appointment of Sergio Marullo di Condojanni as CEO. Marullo di …

Appointment

Alvotech appoints Lisa Graver as CEO

February 3, 2026
Alvotech, CEO

Alvotech has announced the appointment of Lisa Graver as CEO, following the retirement of Róbert Wessman. Wessman served as Chairman …

Appointment

Pace appoints Ken Beyer as CEO

December 10, 2025
CEO, Pace Analytical

Pace, a science and technology company specialising in environmental and life sciences laboratories, has announced the appointment of Ken Beyer …

Appointment

ViVac Pharma appoints Keren Leshem as CEO

November 26, 2025
CEO, Oncology, ViVac Pharma

Early-stage biotechnology company ViVac Pharma has appointed Keren Leshem as its new CEO. Leshem brings almost 30 years of experience …

Appointment
handshake-2056023_960_720

PolyNovo welcomes Bruce Peatey as CEO

October 22, 2025
CEO, Market Expansion, PolyNovo, medtech, wound care

PolyNovo, an Australian medtech company specialising in acute complex wound management, has appointed Bruce Peatey as its new chief executive …

Appointment

Sanner appoints new CEO to drive CDMO strategy

August 11, 2025
Contract Manufacturing, Manufacturing and Production CEO, Corporate, Sanner, contract development and manufacturing organisation

German packaging solutions company, Sanner, has announced a significant leadership change as it advances its transformation into a contract development …

Appointment

Aragen appoints Aniel Khubchandani as CEO of development and manufacturing solutions division

August 8, 2025
Manufacturing Services, Manufacturing and Production Aragen Life Sciences, CEO, Corporate, development and manufacturing solutions, manufacturing services

Aragen Life Sciences, based in Hyderabad, India, has appointed Aniel Khubchandani as CEO of its development and manufacturing solutions (DMS) …

Appointment

Cube Biotech appoints Michael Bencak as new CEO amid global expansion plans

July 25, 2025
Mergers and Acquisitions, Research and Development CEO, Corporate, Cube Biotech, IBA Lifescience, archimed, executive chairman

Cube Biotech has announced a leadership transition as the company continues its trajectory of global growth and innovation in protein …

Appointment

Jazz Pharmaceuticals appoints Renée Galá as CEO to lead next phase of growth

July 16, 2025
Research and Development CEO, Corporate, Neurology, Oncology, jazz pharmaceuticals, neurology, neuroscience

Jazz Pharmaceuticals has named Renée Galá as its next chief executive officer (CEO), effective 11 August 2025. Galá, currently president …

Appointment

Norstella appoints Kris Joshi as CEO to drive next phase of growth

July 10, 2025
Business Services, Consultancy CEO, Corporate, HealthTech, Norstella

Pharma intelligence solutions provider, Norstella, has appointed health-tech leader, Kris Joshi, as its new chief executive officer (CEO) with former …

Appointment

Nick Challoner appointed CEO of Ingenza to drive further growth

July 4, 2025
Business Services, Manufacturing and Production CEO, Corporate, Ingenza, contract research development and manufacturing organisation (CRDMO), president

Ingenza, a Scottish contract research, development and manufacturing organisation (CRDMO), has announced the appointment of Nick Challoner as chief executive …

Appointment

Ochre Bio appoints Quin Wills as CEO to lead next phase of liver therapeutics development

June 30, 2025
Research and Development Boehringer Ingelheim, CEO, GSK, Hepatology, Ochre Bio, RNA therapeutics, chronic liver disease, clinical genomics

Oxford-based biotechnology company Ochre Bio has announced the appointment of Quin Wills as CEO. As co-founder of the company and …

Appointment

Opterion Health strengthens board with appointments of Rice Powell and Mark Hahn

June 25, 2025
Research and Development CEO, Nephrology, Opterion Health, board of directors, cfo, chronic kidney disease, dialysis solution

Swiss life sciences company Opterion Health has appointed two senior industry figures to its board of directors: Rice Powell, former …

Appointment

MC2 Therapeutics appoints Trine Ahlgreen as new CEO

May 27, 2025
Research and Development, Sales and Marketing CEO, Corporate, MC2 Therapeutics, Skin, inflammatory skin conditions

MC2 Therapeutics, a Danish pharma company focused on topical therapies for inflammatory skin conditions, has appointed Trine Ahlgreen as CEO. …

Appointment

Tozaro appoints Jason Slingsby as CEO to lead commercial strategy in cell and gene therapy sector

May 1, 2025
Manufacturing Services, Manufacturing and Production, Research and Development CEO, CGT, Jason Slingsby, Michele Pedrocchi, Pharmacy, Tozaro, manufacturing

Tozaro, a technology provider specialising in cell and gene therapy (CGT) manufacturing, has appointed Jason Slingsby (pictured left) as its …

Appointment
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026